{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T00:41:17Z","timestamp":1708735277505},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,24]]},"DOI":"10.7759\/cureus.18239","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T12:09:03Z","timestamp":1708690143000},"source":"Crossref","is-referenced-by-count":0,"title":["Bullous Erythema Multiforme Secondary to Trimethoprim-Sulfamethoxazole Use, Treated With Cyclosporine in a 91-Year-Old Male"],"prefix":"10.7759","author":[{"given":"Simon","family":"Kashfi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley A","family":"Radparvar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoseli","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sapna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shorabh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05348.x","article-title":"Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist","volume":"51","author":"Sokumbi O","year":"2012","unstructured":"Sokumbi O, Wetter DA. Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist. Int J Dermatol. 2012, 51:889-902. 10.1111\/j.1365-4632.2011.05348.x","journal-title":"Int J Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14118","article-title":"Erythema multiforme, Stevens-Johnson syndrome\/toxic epidermal necrolysis - diagnosis and treatment","volume":"18","author":"Gr\u00fcnwald P","year":"2020","unstructured":"Gr\u00fcnwald P, Mockenhaupt M, Panzer R, Emmert S. Erythema multiforme, Stevens-Johnson syndrome\/toxic epidermal necrolysis - diagnosis and treatment. J Dtsch Dermatol Ges. 2020, 18:547-53. 10.1111\/ddg.14118","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.15406\/oajtmr.2018.02.00052","article-title":"Erythema multiforme: a case series and review of literature","volume":"2","author":"Nair K","year":"2018","unstructured":"Nair K, Chaudhuri K, Ashok L. Erythema multiforme: a case series and review of literature. Open Access J Transl Med Res. 2018, 2:124-30. 10.15406\/oajtmr.2018.02.00052","journal-title":"Open Access J Transl Med Res"},{"key":"ref4","article-title":"Erythema multiforme: recognition and management","volume":"100","author":"Trayes KP","year":"2019","unstructured":"Trayes KP, Love G, Studdiford JS. Erythema multiforme: recognition and management. Am Fam Physician. 2019, 100:82-8.","journal-title":"Am Fam Physician"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2004.00130.x","article-title":"Intermittent oral cyclosporin for recurrent herpes simplex-associated erythema multiforme","volume":"46","author":"Bakis S","year":"2005","unstructured":"Bakis S, Zagarella S. Intermittent oral cyclosporin for recurrent herpes simplex-associated erythema multiforme. Australas J Dermatol. 2005, 46:18-20. 10.1111\/j.1440-0960.2004.00130.x","journal-title":"Australas J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.3957","article-title":"Stevens-Johnson Syndrome and toxic epidermal necrolysis","volume":"153","author":"Ergen EN","year":"2017","unstructured":"Ergen EN, Hughey LC. Stevens-Johnson Syndrome and toxic epidermal necrolysis. JAMA Dermatol. 2017, 153:1344. 10.1001\/jamadermatol.2017.3957","journal-title":"JAMA Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-017-0530-y","article-title":"Stevens-Johnson Syndrome and toxic epidermal necrolysis: a concise review with a comprehensive summary of therapeutic interventions emphasizing supportive measures","volume":"34","author":"Schneider JA","year":"2017","unstructured":"Schneider JA, Cohen PR. Stevens-Johnson Syndrome and toxic epidermal necrolysis: a concise review with a comprehensive summary of therapeutic interventions emphasizing supportive measures. Adv Ther. 2017, 34:1235-44. 10.1007\/s12325-017-0530-y","journal-title":"Adv Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5070\/D3232033968","article-title":"Generalized bullous fixed drug eruption treated with cyclosporine","volume":"23","author":"Malviya N","year":"2017","unstructured":"Malviya N, Cyrus N, Vandergriff T, Mauskar M. Generalized bullous fixed drug eruption treated with cyclosporine. Dermatol Online J. 2017, 23:1-3. 10.5070\/D3232033968","journal-title":"Dermatol Online J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/all.12881","article-title":"Drug allergies documented in electronic health records of a large healthcare system","volume":"71","author":"Zhou L","year":"2016","unstructured":"Zhou L, Dhopeshwarkar N, Blumenthal KG, Goss F, Topaz M, Slight SP, Bates DW. Drug allergies documented in electronic health records of a large healthcare system. Allergy. 2016, 71:1305-13. 10.1111\/all.12881","journal-title":"Allergy"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2019.08.004","article-title":"Drug-induced severe cutaneous adverse reactions: Determine the cause and prevention","volume":"123","author":"Zhang C","year":"2019","unstructured":"Zhang C, Van DN, Hieu C, Craig T. Drug-induced severe cutaneous adverse reactions: Determine the cause and prevention. Ann Allergy Asthma Immunol. 2019, 123:483-7. 10.1016\/j.anai.2019.08.004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.12.014","article-title":"Toxic epidermal necrolysis: five years of treatment experience from a burn unit","volume":"67","author":"Firoz BF","year":"2012","unstructured":"Firoz BF, Henning JS, Zarzabal LA, Pollock BH. Toxic epidermal necrolysis: five years of treatment experience from a burn unit. J Am Acad Dermatol. 2012, 67:630-5. 10.1016\/j.jaad.2011.12.014","journal-title":"J Am Acad Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.05.034","article-title":"Sulfonamide hypersensitivity: fact and fiction","volume":"7","author":"Khan DA","year":"2019","unstructured":"Khan DA, Knowles SR, Shear NH. Sulfonamide hypersensitivity: fact and fiction. J Allergy Clin Immunol Pract. 2019, 7:2116-23. 10.1016\/j.jaip.2019.05.034","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/230386","article-title":"Cyclosporine: a review","volume":"2012","author":"Tedesco D","year":"2012","unstructured":"Tedesco D, Haragsim L. Cyclosporine: a review. J Transplant. 2012, 2012:230386. 10.1155\/2012\/230386","journal-title":"J Transplant"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1990.01670270129025","article-title":"Cyclosporine therapy for bullous erythema multiforme","volume":"126","author":"Wilkel CS","year":"1990","unstructured":"Wilkel CS, McDonald CJ. Cyclosporine therapy for bullous erythema multiforme. Arch Dermatol. 1990, 126:397-8. 10.1001\/archderm.1990.01670270129025","journal-title":"Arch Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000513469","article-title":"Severe generalized bullous fixed drug eruption treated with cyclosporine: a case report and literature review","volume":"13","author":"Barootes HC","year":"2021","unstructured":"Barootes HC, Peebles ER, Matsui D, Rieder M, Abuzgaia A, Mohammed JA. Severe generalized bullous fixed drug eruption treated with cyclosporine: a case report and literature review. Case Rep Dermatol. 2021, 13:154-63. 10.1159\/000513469","journal-title":"Case Rep Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/69953-bullous-erythema-multiforme-secondary-to-trimethoprim-sulfamethoxazole-use-treated-with-cyclosporine-in-a-91-year-old-male","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T12:09:07Z","timestamp":1708690147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/69953-bullous-erythema-multiforme-secondary-to-trimethoprim-sulfamethoxazole-use-treated-with-cyclosporine-in-a-91-year-old-male"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.18239","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,24]]}}}